Jorjin Technologies Inc. and MultiSet AI Inc. announced a strategic collaboration to develop wide-area spatial computing applications for ultra-lightweight AR glasses. The collaboration brings together Jorjin's AR glasses and wearable system integration capabilities with MultiSet's visual positioning system (VPS) and spatial mapping platform, with the goal of enabling more practical hands-free guidance, indoor positioning, and future Physical AI workflows in real-world enterprise environments.

The initial focus will be on facility-scale and large indoor spaces where GPS is unavailable and where workers, visitors, service robots, or AI agents need to share a consistent understanding of location and context. Target scenarios include manufacturing sites, logistics facilities, hospitals, museums, smart restaurants, and other enterprise environments that require reliable spatial awareness without adding heavy infrastructure, according to a press release.

A Practical Wearable Interface for Spatial Computing

Jorjin's ultra-light AR glasses series is designed for application development and enterprise integration. Its recent J9 Eye-Tracking AR Glasses are positioned around a sub-50g form factor, optional full-color near-eye display, compact eye-tracking module, camera, wireless connectivity, and SDK support. These capabilities make the glasses a practical interface for frontline users who need to keep their hands free while receiving contextual information in the field.

By integrating a spatial positioning layer, ultra-light AR glasses can move beyond static information display. The device can understand where the wearer is, what asset or zone the wearer is facing, and when location-specific guidance should be delivered through visual, audio, or gaze-based interaction.

Related XGIMI’s MemoMind AI Glasses Are Crafted for the Mindful

MultiSet's Spatial Mapping Layer

MultiSet AI provides an enterprise VPS and spatial mapping platform for building and operating spatial applications across devices. Recent MultiSet releases have expanded wearable VPS support, MapSet management, map versioning, Android on-device VPS, VPS Gen2, and pipelines that connect 360-degree capture or 3D Gaussian Splatting data to VPS maps. These capabilities are relevant for enterprises that need to create, maintain, and reuse spatial maps as operational infrastructure.

Collaboration Focus

• Wide-area AR guidance: validate hands-free indoor navigation, asset-level work guidance, and location-aware service workflows on Jorjin ultra-light AR glasses.
• Spatial map interoperability: explore how facility scans, digital twin data, 360 capture, and 3D Gaussian Splatting assets can support reusable VPS maps for enterprise sites.
• Physical AI readiness: evaluate how AR glasses, AI agents, robots, and spatial maps can share a common coordinate layer for human-machine collaboration in future pilots.
• Enterprise deployment fit: assess privacy, network, edge, and on-premise deployment options for sensitive industrial, healthcare, and public-space applications.

Executive Perspectives

"Ultra-lightweight AR glasses can become a practical frontline interface only when they are connected to the physical space around the user," said Tom Liang, Chairman of Jorjin. "Working with MultiSet allows us to explore a spatial layer that can support wide-area guidance, contextual AR information, and future Physical AI collaboration in enterprise environments."

"VPS and spatial maps become more valuable when they reach devices that people can wear naturally throughout the workday," said Shadnam Khan, Co-Founder & COO of MultiSet AI. "Jorjin's AR glasses provide an important hardware platform for validating how spatial intelligence can support real operations, from navigation and work instructions to human-robot coordination."

About Jorjin Technologies

Jorjin Technologies Inc. is a Taiwan-based AR/XR smart glasses and wearable platform solution provider. The company develops ultra-light AR glasses, eye-tracking smart glasses, rugged industrial AR headsets, SDKs, and related wireless modules for enterprise and application-development markets.

About MultiSet AI

MultiSet AI Inc. is an enterprise visual positioning and spatial mapping company. Its platform supports VPS, 3D mapping, object tracking, MapSet workflows, and cross-device spatial applications for AR, robotics, and physical-world AI use cases.

Although doctors support wearable technology and believe it can enhance patient care, there are still major obstacles in the way of its inclusion into clinical practice.

A survey of over 2,000 doctors in six nations (the US, Canada, UK, France, Germany, and Spain) revealed that the majority of doctors (97%) reported reviewing wearable data in some capacity and that wearable data offer at least some clinical advantage for patient treatment. Just 3% of doctors claim to never examine this kind of information.

The most commonly reviewed data categories are broadly similar across countries: heart physiology, activity and function, biometric/physical events and alerts, and sleep.

The survey indicates that 74% of doctors outside of the United States and 77% of doctors in the United States believe wearable data has some clinical benefit.

According to a survey by Medscape and the American Medical Association's Center for Digital Health and AI, 82% of doctors really utilize wearables.

According to the study results, clinicians generally recognize the importance of data from activity trackers, smartwatches, and biosensors; nevertheless, structural obstacles more than a lack of motivation prevent extensive clinical integration, reports Heather Landi in Fierce Healthcare.

The study looked at how doctors use patient-generated wearable data, reimbursement, workflow issues, adoption factors, and faith in the validity of the data.

"What surprised me is that the technology is ahead of the healthcare system, not ahead of physicians," American Medical Association CEO John Whyte, M.D., told Fierce Healthcare. "The systems are not set up to maximize that data for clinical impact."

The data needs to be actionable and not just available, Whyte noted.

Related Wearable Patches: $15B Market, Poor Fit for Elderly

The survey found that when patients ask their doctors to review wearable data, physicians typically act, with consistent responses across countries.

Although it differs by nation, wearable data integration into standard clinical practice is still somewhat limited. Less than 6% of doctors in all the nations under study already incorporate wearable data into their workflows.

Germany and Spain have the largest reported near-term pipelines of physicians ready to integrate these data, whereas fewer than one in five physicians in Canada or the United Kingdom indicated a high likelihood of integration in the next 12 months.

According to the paper, health tech businesses and manufacturers of medical devices must establish clinical credibility through proof. Specialty-stratified algorithm accuracy reports that compare each type of detection data to specified medical-grade standards should be published by medical device manufacturers.

For consumer wearable data, health IT businesses must adopt and support Fast Healthcare Interoperability Resources (FHIR)-based standards to facilitate consistent ingestion, according to AMA. In order to seamlessly integrate wearable data into physician workflows, health tech and EHR firms must develop features like auto-uploading confirmed data into the EHR in a structured format in place of "phone-based" review.

Additionally, bias checks should be incorporated into data standards by health tech vendors. For example, they should make it obvious where algorithms have been verified and where performance is unknown.

Every day, thousands of women going through IVF treatment have blood drawn to monitor their hormone levels. It happens every two to three days, throughout the entire cycle — not because the science demands it to be invasive, but simply because no better tool has existed. Level Zero Health is changing that.

The London-based startup has developed a wearable biosensor patch that reads hormone levels directly from interstitial fluid — the fluid surrounding cells just beneath the skin — delivering results with 98% accuracy across the full clinical range. No blood draw. No urine test. No 12-hour delay waiting for results. Just a patch worn on the upper arm, measuring in the background.

‍

The Technology Behind It

What makes Level Zero Health's approach distinctive is its use of proprietary DNA-based biosensors — a departure from the electrochemical sensing methods most competitors rely on. These biosensors are engineered to detect trace concentrations of hormones — progesterone, estrogen, cortisol, and testosterone — at the sensitivity levels required for clinical decision-making. The company achieved 98% accuracy across the human clinical range within their first year of development, a milestone that typically takes far longer in medical device R&D.

The technology draws a deliberate parallel to continuous glucose monitors (CGMs), which transformed diabetes care by making blood sugar data continuous, accessible, and actionable. Hormones have remained a generation behind — until now.

‍

From Clinic to Consumer

The company's go-to-market strategy is deliberately clinical first. Their near-term device — a single-use intermittent patch — targets IVF monitoring and testosterone replacement therapy (TRT), two use cases where frequent hormone data directly influences treatment decisions. They have already secured $3 million in letters of intent from major IVF clinics, signalling strong institutional demand ahead of launch.

A continuous monitoring version is in development for 2028 — the longer-term vision being a device that tracks hormonal patterns across the full cycle, with implications for fertility, perimenopause, athletic performance, and beyond.

In February 2025, Level Zero Health closed a $6.9 million pre-seed round — the largest pre-seed ever raised by a female-founded company in Europe — led by Swiss VC Redalpine, with participation from HAX (SOSV) and Entrepreneur First.

‍

About Level Zero Health

Level Zero Health is a London-based femtech medical device startup developing non-invasive hormone monitoring technology. Founded in 2023 by Ula Rustamova (CEO) and Irene Jia (CTO), the company is pursuing FDA clearance and CE marking for its first clinical device.

Swiss healthtech brand Hilo, developed by Aktiia has closed a $19 million Series B extension, bringing its total funding to more than $119 million. The company also announced U.S. launch of Hilo Core, a wearable system designed to help consumers observe blood pressure patterns over time.

The round includes new investment from Dell Family Office, alongside continued backing from existing investors, as Hilo expands its presence in the U.S. following the launch of Hilo Core, its next-generation blood pressure monitoring system designed to provide continuous, long-term health insights.

Hilo Core consists of a connected upper-arm cuff, a smartphone app, and a lightweight wristband. Customers use the FDA-approved cuff to collect standard blood pressure measurements in order to calibrate the wristband, according to MobiHealth News.

The wristband then estimates blood pressure without repeatedly inflating an arm cuff by using photoplethysmographic signals (optical sensors to detect changes in blood flow under the skin) and algorithms.

According to Hilo, it gathers 30 to 35 readings every day, including overnight, and shows trends in addition to heart rate, sleep, and step count information.

Related FDA Clears Hilo Band: First Cuffless BP Monitor for OTC Use

"For too long, blood pressure has been measured in isolated moments, leaving critical gaps in understanding," Stefan Petzinger, CEO of Hilo by Aktiia, said in a statement.

According to Hilo, customers may use the system to track how their blood pressure-related patterns vary throughout the day and how they connect to things like activity and sleep.

These trends may encourage a user to consult a healthcare provider or take a traditional reading using the arm cuff.

However, the estimates produced by the bracelet shouldn't be used to replace readings from an FDA-approved medical device, diagnose hypertension, or modify medicine.

The FDA has not authorized Hilo Core.

Instead of presenting it as a tool for detecting or treating a medical ailment, the business is marketing it as a general wellness product meant to increase awareness and guide lifestyle choices.

In the future, Hilo intends to develop its product into a regulated medical platform.

Designed for lifelogging hobbyists, VibeLens' new MusicCam Pro offers a wearable action camera that performs all the regular duties of a wearable bone conduction music player.

In October of 2025, VibeLens launched the MusicCam, a bone-conduction open-ear music headset with a 2K camera with a six-axis stabilized lens and waterproofing up to 20 meters (65 feet). This was the company's first and most relevant Kickstarter campaign. Designed for bicycling, hiking, and diving, the MusicCam swiftly garnered over 2,300 backers and US$500,000 in funding, eventually surpassing its initial Kickstarter target by a factor of 100, reports Mike Hanlon in New Atlas.

VibeLens has developed the MusicCam Pro, a major improvement over the original MusicCam that goes beyond simply quadrupling the video resolution from 2K to 4K, after learning from the experiences and feedback of those first-generation backers.

Related DJI Osmo Action 4 Review: A Powerful GoPro Rival

VibeLens uses a lens module that allows the lens to slide out by up to half a centimeter (to reduce obstructions) and gives it a ±15° vertical adjustment so you can align it with your line of sight and check it out on your phone before starting your adventure. This helps bring the framing of the MusicCam V2.0 much closer to the ideal.

One of the most important claims about the new MusicCam Pro is that its built-in AI editing helps transform the raw footage into better and faster shareable content.

With a 600-mAh battery that can be charged to 80% in 35 minutes, the MusicCam Pro can record voices for 8 hours, shoot videos for 96 minutes, or play music for 15 hours.

Having seen a very similar setup with the Zygo, the optional 9,500-mAh charging case makes a lot of sense, especially when combined with a spare MusicCam Pro. It protects, recharges, and organizes everything in one case, which is comforting when you're traveling between adventures and have a place for all the bits.

The MusicCam Pro is now priced at US$229 including shipping on Kickstarter. Delivery is anticipated in September, at which point the MSRP will be $399. For $299 with delivery, another Kickstarter launch special offers the MusicCam Pro, Charging Case, and a one-year Creator Membership—a $309 discount above the final retail price of $608.

The next generation of battery-operated wearable technology, assistive devices, robotics, and drones may include a novel 3D camera modeled like the eyes of jumping spiders. The technology utilized less energy than a nightlight.

SpiderCam, a prototype developed by Northwestern University engineers mimics how spiders use their sight to measure distances before making an unexpected sideways leap at an unsuspecting victim going about its daily activity, reports Shiri Leigh in New Atlas.

“Jumping spiders jump to catch prey, to avoid predators and to get around, and that requires excellent vision,” says Northwestern’s Asst. Prof. Emma Alexander, the study’s corresponding author and expert in bio-inspired computer vision.

The majority of common 3D cameras take pictures from different angles in order to determine depth, either by measuring and projecting light or by comparing each image. These techniques require a large amount of processing power, costly gear, and energy.

Read more Brain Implant Sends Messages to the Brain With Light

While jumping spiders have numerous layers of retinas in each eye that may independently concentrate at slightly varying distances—one layer may see an object in focus while another layer sees the identical thing slightly out of focus—human eyes are only able to focus on one retina.

“They see multiple levels of focus at all times,” Alexander says. “So, they are always collecting pairs of images. Then, their brains could compare these differences in sharpness to judge distance.”

“But their brains are very small – the size of a poppy seed – so they have to compute these distances in a highly efficient way. We wanted to understand whether we could borrow some of the same principles to create an extremely energy-efficient depth sensor that could be used in resource-constrained situations where users don’t have unlimited access to power.”

Similar functionality is provided by the SpiderCam, which uses a specially designed camera to simultaneously capture two photos with slightly different focus settings. The researchers developed a unique algorithm straight onto a specially programmed computer chip optimized for energy-efficient processing, rather than executing resource-intensive software on a traditional processor.

According to the team, the SpiderCam is the first 3D camera to run on less than one watt. The chip prototype can process depth maps at 32.5 frames per second while consuming just 624 milliwatts of power. The data is then transformed into real-time depth measurements by the unique algorithm, which analyzes how the two images' edges and textures differ in sharpness.

Sky Labs, a medical device firm best known for its blood pressure monitoring ring, has filed for a KOSDAQ listing with South Korea's Financial Services Commission and is now getting ready for an IPO.

According to reports, the business intends to offer 2 million shares with the goal of raising up to 32 billion won ($21.5 million) to fund its expansion into pharmaceutical clinical trials and transition into a medical data platform company.

The IPO filing comes after the introduction of what Sky Labs claims to be the first BP ring for ward use in history, as well as regulatory clearances in Europe and the UK earlier this year. After verifying that Sky Labs' ring functioned similarly to traditional BP monitoring techniques, the Korean Society of Hypertension (KSH) has offered what may be the first formal recommendation of ring-type cuffless BP devices in history.

We believe now is the right time for an IPO because, with our unrivalled technology, we have successfully established ourselves within the regulated medical market while demonstrating strong financial growth. Our product, CART BP pro, is the first wearable cuffless BP monitor to obtain both medical device approval and health insurance reimbursement coverage, and is now used in about 2,000 hospitals and clinics nationwide. We have moved beyond technological validation to a business model in which recurring clinical use generates revenue, Sky Labs CEO Jack Byunghwan Lee told MobiHealth News.

The company said its revenue had grown more than 13-fold in just two years, rising from approximately 600 million won ($405,000) in 2023 to 4.1 billion won ($2.8 million) in 2024 and 7.9 billion won ($5.3 million) in 2025. It added that first-quarter revenue this year reached 2.1 billion won ($1.4 million), representing a 354% increase compared with the same period last year. The company also reported that its gross profit turned positive, reaching approximately 3.9 billion won ($2.6 million) in 2025.

He also said Sky Labs’ planned KOSDAQ listing would mark a significant milestone in its transformation from a ring-type wearable technology company focused on blood pressure monitoring into a platform enterprise that continuously generates vital-sign data. It said the credibility and capital raised through the listing would enable it to diversify its technology portfolio to monitor additional vital signs while expanding its clinical data platform business.

Related Galaxy Ring 2: How Samsung Could Beat the Oura Ring 5

Byunghwan Lee also noted that its CART BP Pro device has already been adopted in a large-scale cohort study led by the National Institute of Health under the Korea Disease Control and Prevention Agency. According to the company, the adoption represents an important first step in its transition into a clinical data platform business, demonstrating that the strategy is already being implemented rather than remaining a future plan.

He said his company expects to raise between 26 billion won ($17.5 million) and 32 billion won ($21.5 million) through the offering. They plan to use these proceeds primarily in three key areas.

First, the company will improve its ring-type BP monitors, which it currently sell to both hospitals and consumers, by reducing their weight and increasing their durability.

Second, the company will expand its product lineup and develop an AI medical data platform.

Third, it will secure clinical evidence and accelerate the process of obtaining overseas regulatory approvals.

While conventional medical AI companies have focused on analyzing data accumulated within hospitals, Sky Labs differentiate itself by having established a structure to generate valuable medical data directly through wearable devices, according to Byunghwan Lee.

“For hospitals and clinicians, we provide vital sign data from patients 24 hours a day outside the office, supporting more precise and multifaceted diagnoses. Patients can measure their vital signs comfortably during their daily lives,” Byunghwan Lee said.

Furthermore, for pharmaceutical partners, we plan to provide real-world vital sign data for clinical trials, opening up a new avenue for collaboration to evaluate drug performance and expand indications.”

Penn State engineers are fusing science and art to produce cute, paint-on tattoos that have the potential to power robotic limbs, monitor brain waves, and detect heart attacks early. The system is colorful, personalized, and readily washable.

The team has created a conductive ink that can power sensors and be applied straight to a person's skin in whatever design they can think of, and they have filed a provisional patent for it. They are not only more fashionable than existing wearable sensor designs, but they are also more sensitive, robust, and accurate since the ink, which can be colored with any desired color, employs materials that connect better with the skin. The findings were described in a report that was published in the Proceedings of the National Academy of Sciences.

According to Larry Cheng, corresponding author on the paper and James L. Henderson Jr. Memorial Professor of Engineering Science and Mechanics at Penn State, wearable healthcare systems are powered by electrode contacts affixed to the body.

Conventional electrode designs use stiff, metal-based materials that provide stability but have trouble adhering to the body during exercise or movement. Hydrogel, a soft, jelly-like substance that can absorb and swell with water to stretch and better mimic the body's movement, is used in many experimental designs, such as the ones Cheng has been studying for more than ten years. However, over time, this substance may dry, which would result in the electrodes losing their stretchiness and adherence, reports Ty Tkacik in Penn State.

Wanqing Zhang, an engineering science and mechanics doctoral candidate and first author on the paper, explained that it’s not just the electrodes peeling off that contributes to less accurate sensor readings, but the actual act of applying them. Many commercial sensors have trouble accurately recording what is happening inside a patient's body, especially when applied to hairy or sweaty skin.

The team mixed several different types of polymers, or plastics, and acidic additives into a water-based solution to create the ink. It has the consistency of glue when wet but can dry onto the skin in less than 10 minutes, Zhang said. Drying can be accelerated with the help of a hair dryer.

“The ink itself almost behaves like face paint,” Cheng explained. “It starts out almost transparent, but you can use food dye to pigment the ink into whatever colors you need to paint whatever design you have in mind — like a cartoon or Superman. This allows us to completely personalize the wearable to a person’s preference."

Related Wearable Sticker Can Identify Real Human Emotions

The team revealed that its electrode-powered sensors are highly responsive and adjustable. According to Zhang, applying the material directly to the skin improves measurements since it better adapts to the texture of the skin. A connecting area of the electrodes is painted onto a porous, silver cloth that resembles metal fabric and is applied to the skin in order to improve the stability between the electrodes and the sensors they inform. Before solidifying and adhering to the skin's surface, the wet ink seeps into the fabric. The larger electric module, which is glued to the wearer's skin beneath their clothing, has the connected part hooked into a port. This larger module uses Bluetooth to wirelessly send the electrical impulses that the ink has collected to a computer.

In addition to more evenly adhering to the texture of the skin and efficiently recording electrical signals, the electrodes may expand to more than 150% of their original size without breaking because to the textile's porosity composition.

In one experiment, the team demonstrated that the painted electrodes could successfully track a co-author's ECG readings over a 12-hour period of daily activities. In another test, a different co-author tracked their readings during an exercise routine, demonstrating that the electrodes maintain adhesion and accuracy even during physical activity. In a different test, the scientists monitored a co-author's forearm EMG signals and sent them to a robotic prosthetic, allowing the person to operate the robotic hand without coming into contact with it.

This work was supported by the U.S. National Science Foundation and the National Institutes of Health.

The X1 bone conduction headset from New York-based Auriview is now available on Kickstarter. It records everything you see and hear, has an integrated AI assistant that allows voice commands for interaction, and lets you ask questions and stay in touch without continuously reaching for your phone.

Cyclists, runners, hikers, commuters, and those who frequently engage in the age-old practice of using their hands when outdoors make up the most obvious audience. You can listen to audio while still hearing traffic, trail talk, suspicious branches, or the precise instant your companion remarks, "This shortcut is probably fine," since bone conduction keeps the ear canal open. Additionally, the headset's low profile allows it to fit under many cycle helmets and possibly some ski helmets. This is the kind of useful feature that distinguishes wearable technology from "cool in a render, doomed in a drawer,” reports odditymall.

The majority of headsets are designed for listening. X1 is designed to see, hear, comprehend, record, translate, navigate, and maintain connectivity while moving. It is a wearable AI device that has an HD point-of-view camera, AI visual recognition, open-ear bone conduction audio, real-time translation, smart recording, live streaming, app media management, Wi-Fi 6, BLE 5.4, dual-mic noise reduction, IPX8 waterproofing, IP6X dust protection, and a lightweight 48g body.

The integrated camera uses a 130-degree wide-angle lens to capture 4K footage at 30 frames per second. Because the camera is stationary rather than rotating like a tiny robot periscope, that field of view is important. Though anyone hoping for GoPro-level control should keep in mind that this is still a little headset rather than a chest-mounted documentary crew, Auriview claims that the broad lens helps cover the view in front of you.

Related Cardo Systems-509 to Transform Motorcycle Helmets

Voice recording and translation are also supported by the X1. English, Chinese, Japanese, Korean, Spanish, French, German, Italian, Portuguese, Russian, and Arabic are among the languages in which face-to-face interactions can be translated.

Those who choose lightweight, open-ear audio with sporadic camera and AI features will find the X1 more appealing than those who prioritize the highest level of video quality. The helmet-friendly design and open-ear awareness may appeal to commuters and cyclists. The hands-free camera and object recognition might be appealing to hikers. Voice notes and translation could be very helpful to travelers. Owning headphones that seem like they've swallowed a tour guide will just be fun for techies.

Millions of people around the world live with cardiac arrhythmia—a condition where the heart's rhythm goes too fast, too slow, or falls out of sync entirely. The standard fix has long been a surgically implanted pacemaker, complete with leads threaded into the heart itself. Effective, yes, but not without risk: infection and tissue damage are real possibilities whenever you're cutting someone open. Now, a joint team from MIT and USC has come up with something that skips the scalpel altogether—a wearable patch, applied like a sticker to the chest, that regulates heartbeat using nothing but ultrasound.

"Ultrasound offers a unique combination of deep tissue penetration, spatial focusing and non-invasive delivery," says Chen Gong, the study's first author and a researcher at USC. Earlier attempts at ultrasound-based pacing had stumbled—either the results weren't consistent, or the method depended on injected microbubbles to work at all. Gong's team took a different route, borrowing from a field called sonogenetics. The idea: genetically tweak heart cells so they become responsive to sound waves. Once those modified cells pick up an ultrasound pulse, ion channels swing open, calcium rushes in, and the cell contracts—essentially giving researchers a remote switch for heartbeat, reports Physics World.

"Our central motivation was to address the limitations of conventional pacemakers, while preserving precise control of cardiac rhythm," Gong explains.

Testing It Out

Before building any hardware, the team checked whether the concept even held up in a dish. Using human heart muscle cells that had been sonogenetically altered, they found that ultrasound pulses got roughly 75% of the engineered cells beating in lockstep with the sound waves. Cells that hadn't been modified simply ignored the signal. Just as important, the ultrasound exposure didn't trigger any red flags in the cells—no spike in inflammation markers, no signs of injury or oxidative stress—suggesting the approach is safe, at least at this stage.

Introducing the Device

Building on those results, the researchers engineered what they call a non-invasive ultrasound pacemaker, or NUP—detailed in a paper published in Nature Biomedical Engineering. It's roughly the size of a postage stamp, adheres to skin using a bioadhesive layer, and packs in a 64-channel phased-array transducer alongside modules for data collection, wireless transmission, and power.

Related Ultrasound Wristband Tracks Hand Movements in Real Time

To see whether it actually worked in a living animal, they tested it on sonogenetically modified rats, sticking the device onto each rat's chest and firing ultrasound through the chest wall toward the heart. At 2 MPa of acoustic pressure with 40-millisecond pulses, the device pushed heart rates up from a baseline of 240 bpm to somewhere between 360 and 540 bpm—and cranking up the pulse repetition frequency pushed rates even higher. The moment the ultrasound stopped, hearts reverted to their normal rhythm on their own. Rats without the genetic modification, by contrast, showed no response to the device at all.

The team also showed off the NUP's precision: it can electrically steer its ultrasound beam to hit targets less than a millimeter apart, meaning it can selectively pace different chambers of the heart. When they induced arrhythmias in the modified rats, the device successfully restored normal rhythm—something that didn't happen in unmodified control animals exposed to the same stimulation.

"A major objective of this work was to move beyond proof-of-concept stimulation and demonstrate a wearable system that could realistically support daily use," notes Qifa Zhou, who leads a research group at USC. "The current prototype integrates imaging, stimulation, wireless communication and battery-powered operation into a wearable format."

Looking Toward the Clinic

A real-world version of this device would need to handle a lot on its own—tracking heart rate, pinpointing the heart's chambers, and delivering stimulation, all without a technician manually steering things. To move toward that, the team built a cloud-based AI system that reads heart rate and calculates targeting coordinates, then adjusts the ultrasound beam accordingly.

They also had to answer a harder question: would this actually work on a human-sized chest? Using simulations plus experiments on a pig heart buried under multiple layers of tissue, they found that even after the ultrasound weakened passing through tissue, it still arrived at roughly 2 MPa—enough to stimulate the heart at clinically meaningful pacing sites.

Safety checks turned up encouraging results too. The ultrasound energy delivered stayed under approved exposure limits, generated barely any heat, and the genetic modification itself didn't cause unwanted immune reactions, off-target effects, or tissue damage in the rats.

"In the long term, we are optimistic about applying sonogenetics in humans," says Gengxi Lu, a co-author from MIT. He's careful to draw a distinction here: sonogenetics isn't gene editing in the sense of permanently altering DNA. Instead, it gets cells to temporarily produce proteins that respond to ultrasound. Still, he cautions, plenty of clinical testing lies ahead before anyone can call it safe or effective long-term in people.

Next on the agenda: refining how the genetic material gets delivered, running trials in larger animals, and building closed-loop systems that pair real-time sensing with adaptive stimulation. There's also the unglamorous engineering side—shrinking the device further, stretching battery life, and making sure it stays put and functions well even as a person moves around.

"For cardiac pacing, we envisage that the final goal of NUP technology is to be a permanent alternative to a long-term implanted pacemaker," Xuanhe Zhao of MIT told Physics World. "More broadly, we are interested in expanding ultrasound-enabled bioelectronic medicine beyond cardiac pacing toward other organs and therapeutic applications where non-invasive, spatially precise modulation could have clinical impact."

In an effort to better understand their health, millions of people worldwide wear fitness trackers and smart rings to monitor their heart rate, body temperature, sleep patterns, and exercise. However, that same technology is being advanced to a higher level during the World Cup.

Players are using physiological data to control tiredness, improve recovery, and unlock even the slightest performance gains in a tournament where the difference between winning and losing can be extremely small, reports Jacqueline Howard and Andrew Quimby in CNN.

Commercial devices like sweat patches, WHOOPs, Oura Rings, and performance vests have been seen being used by athletes to train and compete, demonstrating how consumer wearables are still changing the science of professional sports and, consequently, how athletes of all levels practice.

Sweat patches

Long before the World Cup began, several professional soccer players began wearing commercial wearables.

A sophisticated "sticker" that tracks perspiration was crucial to the Brazilian team's training and preparation in the run-up to the competition.

Smart rings

Oura Ring is another fitness tracker making an appearance at the World Cup. According to Doug Sweeny, chief marketing officer of Oura, the wearable tech company's cooperation with US Soccer allowed the US Men's team to acquire Oura Rings.

Related Catapult Sports GPS for Football Teams

These measures could assist determine when players' bodies might be ready for more strenuous workouts and when they might benefit from more rest before or after training.

Fitness bands

The WHOOP fitness bracelet is one wearable that some players have been using during World Cup games. Sleep, strain, stress, and heart rate are among the health indicators it tracks when worn snugly against the skin on the wrist, bicep, or other WHOOP Body places.

Any athlete's performance can be significantly impacted by travel and sleep disturbances. According to Greg Grosicki, WHOOP’s data scientist, WHOOP data—which was gathered from research studies rather than players—indicates that on days when users record travel or jet lag, heart rate variability can decrease by roughly 9%, sleep performance can drop by up to 6 points, and sleep consistency can decrease by up to 19%.

Performance vests

Sports tech company STATSSports’ GPS tracking systems is being used by twelve nations throughout the World Cup. It is being used mainly in a performance vest that tracks real-time physical metrics including heart rate, speed, and distance.

For the first time, England is offering live in-game GPS performance statistics during a World Cup utilizing STATSports technology. Throughout the competition, coaches and sports scientists can keep an eye on player workloads and physical performance thanks to the technology.

For example, the staff may choose to replace a player with a substitute in order to preserve them if their real-time metrics show that they are overworked, at risk of injury, or exhausted. This option is made because this year's World Cup has more matches than ever before.

The metrics that you can use

The same insights that enable great athletes are increasingly helping regular people better understand their own bodies, whether the objective is to compete on the biggest stage in the world or just feel healthier and more energized every day.

Hydration

One crucial indicator for athletes is hydration since it affects endurance, body temperature regulation, and even cognitive performance.

Sleep

In professional sports, sleep is now one of the performance factors that is monitored the most. Lack of sleep can hinder muscle repair, decrease cognitive function, slow down reaction times, and increase the risk of injury, according to research.

Body temperature

For every athlete, maintaining a healthy body temperature and drinking plenty of water are still essential. much while it was always anticipated that this summer's weather would be difficult, the US heat wave has made keeping an eye on World Cup players' temperatures much more crucial.

Heart rate variability

Heart rate variability, another key metric, provides insight into how well the body’s nervous system is adapting to physical and mental stress, helping athletes balance training intensity with recovery.

Final thoughts

Users should keep in mind that no algorithm is ideal for everyone while utilizing wearable technology, so if you feel like something is wrong, you are the best person to know your own body, according to Benjamin Smarr, a professor in the Department of Bioengineering and the Halicioglu Data Sciences Institute at UC San Diego, who has used the Oura Ring to study health outcomes.

Additionally, you still need to make changes to your regular workout routine, sleep schedule, and other habits in order to take advantage of wearable health data.

Smart glasses with AI capabilities are quickly permeating daily life and frequently merging seamlessly with conventional eyewear. In addition to providing features like real-time translation, word recognition, and augmented reality, devices made by businesses like Meta, Ray-Ban, and Xreal can covertly record images, videos, and sounds. When they are employed in workplaces without others' knowledge, their subtle design presents significant legal issues.

There are already laws in place

Laws like the Data Protection Act 2018 and the UK GDPR treat recorded photos and audio as personal data as soon as they are acquired. Employees who make secret recordings without a clear aim or a legitimate legal reason may be held accountable for adhering to data protection regulations, reports Claire Scanlan in Electronic Specifier.

Intellectual Property Risks and Concerns

The risk of unauthorized collection of private data may be greatly increased by smart glasses. While seemingly doing nothing more out of the ordinary than wearing spectacles, an employee can effortlessly record product designs, process documentation, financial data, and client information. Evidence of that theft usually resides on a personal device, which is frequently outside the purview of regular IT surveillance.

Read more The Most Discreet Smart Glasses Unveiled

The ability to secretly record or transmit information raises concerns that current technology standards were not designed to manage in regulated industries where secrecy is essential, such as finance, healthcare, law, and any business managing commercially sensitive data.

Contractual and Policy Considerations

Smart glasses and other recording devices should be specifically mentioned in employment contracts, which should also state that secret recording without a valid reason could be considered gross misconduct and result in summary dismissal.

However, since a general restriction without that nuance could not hold up in court, employers should note in those same contracts that recording may be justified in some situations, such as collecting proof of discrimination or major safety violations.

The Time to Act Is Now

The regulatory system intended to oversee technology has not kept up with its rapid development, and additional AI integration will widen this gap. When the vulnerability is already existing, the highest-risk approach is to wait for an occurrence before revising contracts and procedures.

One of the biggest advantages of wearable devices is their ability to detect potential health problems before they become serious. However, a key challenge remains ensuring users receive timely guidance from healthcare professionals when a smartwatch or smart ring flags a possible issue.

To bridge this gap, wearable companies Oura and Whoop have introduced virtual healthcare access, allowing users to consult doctors directly through their apps. This could mark an important step toward integrating consumer-generated health data into mainstream medical care. However, experts emphasize that clinical decisions require much stronger evidence than general wellness tracking. So far, only a limited number of wearable features have received regulatory clearance for medical use, and research supporting the use of wearable data in patient care is still developing. As a result, widespread adoption by healthcare providers is likely to take time, reports Mario Aguilar in Stat News.

Whoop suggests that the integration to virtual care can bridge the gap between biometric data collection and expert interpretation and that “these consultations begin with a comprehensive understanding of the member’s health, powered by months of continuous data.”

“Oura is really interesting because they’re able to provide signals on your blood pressure, on your oxygen, on heart rate, on when you may be about to get sick, and those are really powerful signals,” said Muthu Alagappan, CEO of Counsel Health, the virtual provider working with Oura. “And we can now combine that with actionability. We can have a doctor, minutes away that you can chat with, who can write a prescription.”

Related Bearmind Launches Brain Health Wearable

Researchers have explored the role of consumer wearables in healthcare for more than ten years. The discussion gained real momentum in 2018 when Apple introduced an FDA-authorized feature that notifies users of possible irregular heart rhythms. This raised concerns that healthcare providers could face a surge of patients seeking follow-up tests after receiving smartwatch alerts, since wearable data alone is not reliable enough to confirm a medical diagnosis.

Oura offers similar notifications through its Health Radar feature, which monitors signals that may indicate illness or reveal changes in blood pressure or nighttime breathing associated with potential health concerns. According to Oura's Chief Medical Officer, Ricky Bloomfield, the app can educate users about these findings but is not designed to provide personalized medical advice.

Jessilyn Dunn, an associate professor of biomedical engineering at Duke University, said that health metrics such as blood pressure must be accurate and reliable before clinicians can confidently use them in medical decision-making. So far, neither Oura nor Whoop has sought FDA marketing authorization for their blood pressure features or publicly shared detailed accuracy data. At the same time, the FDA has taken a lighter regulatory approach toward devices marketed for general wellness rather than medical diagnosis. Dunn cautioned that wellness features lacking regulatory review could gradually find their way into clinical practice before they are adequately validated.

“The question becomes that line between wellness and medicine,” she said. “I would say if you’re bringing information to a doctor, the doctor is making decisions based off of it, to me, that seems medical. From that perspective, I am concerned about where this all goes.”

Wearable companies are working to build greater confidence in the health data their devices collect. Oura says it has published research supporting features such as Cycle Insights and plans to release documentation for its blood pressure feature soon. According to Oura's Chief Medical Officer, Ricky Bloomfield, a device's scientific accuracy should not be judged solely by whether it has received FDA clearance.

Companies also promote wearable data as a useful resource for medical consultations. Devices like Whoop continuously track metrics including heart rate, sleep, blood oxygen, body temperature, respiratory rate, menstrual health, and lifestyle habits, providing clinicians with a broader picture of a person's health than a single clinic visit.

However, experts remain cautious. Jessilyn Dunn of Duke University noted that while wearable data can reveal trends, it often does not clearly indicate what medical action should follow. Similarly, Mintu Turakhia Dhruva said these metrics are interesting but rarely influence treatment decisions.

Researchers believe wearable data holds enormous long-term potential, but stronger scientific evidence is still needed before it becomes part of routine healthcare. They argue that larger shared datasets and closer collaboration between clinicians and technology companies could help transform wearable information into reliable digital biomarkers that improve diagnosis and patient care.

Even Realities, the Shenzen, China-based smart glasses company, has officially secured unicorn status with its most recent Pre-B financing round, bringing the company $150 million and a $1 billion valuation.

The development of Even Realities' next-generation smart glasses platform, the strengthening of AI integration, and the expansion of international operations are reportedly the main goals of the round, which was spearheaded by Meituan and Tencent.

The company's total funding now stands at $159 million after the most recent round; its initial $9 million Series CDH Investments, Cyanhill Capital, and China Growth Capital were among the investors in one round.

Related Wearlinq Secures $14M to Transform Cardiac Monitoring

Even Realities, which was founded in 2023 by former Apple developers, has set itself apart from many rivals by emphasizing smart eyewear with displays rather than gadgets with cameras.

Will Wang, the firm's founder and CEO, told TechCrunch that the company prioritizes user privacy while aiming to deliver information immediately within the wearer's range of vision. Wang used to work on the iPhone and Apple Watch.

Several well-known Chinese technology backers, including Sequoia China, were among the company's initial investors. In 2024, Even introduced its debut product, the Even G1.

In November of last year, the Even G2, its most recent model, was unveiled. The device lacks a camera, in contrast to several competing smart eyewear. Rather, it is controlled by a companion smart ring and has an integrated heads-up display that enables users to browse features with taps and swipes. The company's approach to privacy is reflected in the decision to leave out a camera.

Prescription lenses and the companion ring raise the average purchase price to about $1,000. The company's smart glasses start at $599 before taxes.

Edge AI involves running artificial intelligence algorithms on wearable devices, where data is processed locally to support immediate analysis and faster decisions.

Wearables were merely data collectors until recently. They would gather the information, transfer it to the cloud, evaluate it, and then send it back to your phone's companion app. Although this was practical, there were certain drawbacks, like delays, a loss of privacy, and a heavy reliance on a strong Wi-Fi connection.

The current state of affairs is shifting in favor of user choices. Moving intelligence from the cloud to the wearable gadget itself is made possible by the development of Edge AI. To put it another way, wearables now do more than just gather data; they also interpret, analyze, and respond to it instantly, reports IOT for All.

Although it might not seem like much at first, this one action alters the user experience as a whole. Imagine improved dependability, more privacy, quicker feedback, and the elimination of the need to constantly search for a strong signal. This change is something you should be aware of if you are concerned about the privacy of your health information, particularly in light of the Flo lawsuit scandal.

Read more UV-Detecting Necklace Monitors Sun Exposure

Understanding the Basics of Edge AI in Wearable Medical Devices

Essential Building Blocks of Edge AI for Medical Wearables

Wearable health devices using edge AI may process data directly on the device, doing away with the requirement for continuous cloud access. Advanced microprocessors, machine learning algorithms, and hardware optimization enable this targeted processing. Key features include:

• Real-Time Data Processing: Edge AI makes it possible to analyze health parameters like heart rate, oxygen levels, and activity patterns instantly, giving users         instantaneous feedback.

• Low Latency: Edge AI is perfect for time-sensitive applications like identifying arrhythmias or falls since it processes data locally, reducing the latency associated         with cloud-based systems.

• Enhanced Privacy: Sensitive health information is kept on the device, reducing the possibility of breaches and guaranteeing adherence to laws like GDPR and HIPAA.

• Energy Efficiency: Devices with optimized hardware and algorithms use less power, improving battery life and usefulness.

• Offline Functionality: Edge AI makes devices dependable in remote or underserved areas by enabling them to operate without internet connectivity.

How Edge AI Enhances Wearable Health Devices

There are several benefits for users and stakeholders in the healthcare ecosystem when wearable health devices use Edge AI.

• Personalized Healthcare: Edge AI improves patient outcomes by enabling customized recommendations and actions through real-time analysis of individual health         data.

• Cost Efficiency: Manufacturers and healthcare providers can cut operating expenses by relying less on cloud infrastructure.

• Scalability: Edge AI devices are appropriate for population-scale health monitoring since they may be installed in large quantities without taxing cloud servers.

• Better User Experience: Wearables become more efficient and dependable as a result of faster processing and lower latency.

• Support for Preventive Care: By identifying possible health problems before they become serious, predictive analytics and ongoing monitoring assist shift the         emphasis from reactive to preventive care.

The market for wearable health patches is growing rapidly. It is expected to expand by about 10% to 11% each year, increasing from an estimated $13–15 billion in 2026 to more than $20 billion by 2030.

A major reason for this growth is the expansion of home-based healthcare. The Acute Hospital Care at Home waiver, which allows hospitals to provide hospital-level care in patients' homes and receive reimbursement for it, has been extended by Congress until September 30, 2030. According to Lisa Voronkova in MDDI Online, this gives healthcare systems enough time to build long-term home care programs that rely on wearable health sensors instead of treating home care as a temporary solution introduced during the pandemic.

Another important factor is the aging population and the growing shortage of caregivers. As more older adults need medical care and fewer caregivers are available, healthcare is increasingly moving out of hospitals and onto wearable devices that monitor patients from home.

However, this shift also creates a challenge. Many wearable patches are now being used by older adults, whose skin is often thinner and more fragile. Yet most patches are not specifically designed for this group. Despite this important issue, product launch announcements rarely mention the need for patches that are better suited to aging skin.

Patients Who Generate the Pivotal Data Tend To Be Much Younger

Like many clinical trials of continuous glucose monitors (CGMs), the CONNECT study mainly included middle-aged adults. On average, participants began the study with an HbA1c level of 8.8%, indicating that their blood sugar was not well controlled. The study sponsor also reported that the benefits of the CGM were consistent regardless of participants' age, sex, or ethnicity.

Related Jewel - Smart Cardiac Monitoring Patch

However, there is an important limitation. Diabetes is most common among older adults, yet the people enrolled in clinical trials are often about ten years younger and generally healthier than the patients who will eventually use these devices in everyday life. In other words, the device is tested on a healthier group than its real-world users.

This does not mean that CGMs are ineffective. Instead, it highlights the need to understand how these devices perform in the older, less healthy populations who are most likely to depend on them.

Medical Adhesives Are Not Designed For Older Patients

Medical adhesives are not designed for the older patients. According to research on skin mechanics, as people age, their dermis and epidermis thin and their mechanical stability can be reduced by up to four times.

To put it simply, an older patient's skin can be lifted together with its outer protective layer by the same mild tug that removes a 50-year-old's skin with ease.

Long-term care surveys show medical adhesive-related skin injury at around 15% of residents, with hospital studies approaching 7% of inpatients, and greater rates expected in frail older persons.

Only 31% of Adults Aged 75 to 79 Owns A Smartphone

Only roughly 31% people between the ages of 75 and 79 owned a smartphone, according to Pew's most recent comprehensive age breakdown. Although this percentage has since increased, many elderly patients still lack the screen that many systems use as their primary display.

Additionally, the backup hardware is not yet reliable. A flaw in certain Dexcom's handheld receivers prevented them from sounding an audible alarm, which meant that a patient who relied solely on hearing could completely miss the warning. As a result, Dexcom had to update its handheld receivers.

Moving Up The Stack Reveals The Same Recurring Blind Spot

The software layer is also becoming more stringent on its own routine. The EU AI Act's high-risk regulations will start to apply on August 2, 2026, to AI integrated into devices that already require the EU's pre-market conformity review as AI-driven coaching and predictive alerts advance inside these systems. This means that a connected, AI-enabled patch may be subject to both medical-device and AI regulation concurrently.

The next generation of the patch will be determined by the companies who bridge that gap rather than expanding beyond it.

A new skin-like computing patch developed at the University of Chicago Pritzker School of Molecular Engineering can analyze health data using artificial intelligence in an unprecedented way.

Unlike today’s wearable devices, it carries out its AI computations directly on the body, in mere milliseconds, without relying on a wireless connection, reports Sarah C.P. Williams in UChicago News.

While your current smartwatch may be able to track your heart rate or movements, it doesn’t analyze what it finds. The analysis happens elsewhere, after it shuttles data to an external server. In some situations—detecting ventricular fibrillation in the heart, for instance—that few-seconds lag to communicate with the server is too long.

The new device, designed and tested in collaboration with researchers at Argonne National Laboratory, was made possible by new manufacturing processes that allow organic electrochemical transistors to be printed onto flexible surfaces.

Related Wearable Patch Monitors Baby’s Movements in Utero

“The future that we’re trying to realize is to make wearable and implantable devices smarter,” said Sihong Wang, an associate professor of molecular engineering at UChicago and co-senior author of the new study, published in Nature Electronics. “It’s helping people have a personal, instantaneous doctor integrated into their devices.”

Manufacturing stretchy transistors

For years, Wang’s lab has been working to create electronic components that can stretch and bend like human skin, with the goal of creating smart devices that adhere to human tissues. The group previously developed methods for fabricating stretchable transistor array and a stretchable OLED display.

In the new work, Wang and his colleagues set out to build a stretchable neuromorphic computing circuit—a large array of transistors that can run analyses of health data. Earlier work had demonstrated that the concept was theoretically possible with a small number of transistors but hadn’t scaled it up to a practical size.

The new device, designed and tested in collaboration with researchers at Argonne National Laboratory, was made possible by the development of manufacturing processes that allow organic electrochemical transistors to be printed onto flexible surfaces. Photo by John Zich

Saving lives with speedy computing

To test the new devices, Wang’s team used one of their new stretchable arrays to run a pre-trained algorithm designed to help treat ventricular fibrillation.

This dangerous electrical storm in the heart can be fatal and is most often treated with a one-size-fits-all defibrillator shock that delivers a massive jolt of electricity to the entire heart. Researchers have proposed a more precise treatment: mapping abnormal waves of electricity as they move through the heart and delivering small, precise pulses just ahead of them before they can continue.

However, the obstacle has been time. Wavefronts move through the heart so fast that the entire analysis must be completed within milliseconds—far too quickly for data to be transmitted to an external computer and back.

“This is a situation where it’s not feasible to have remote computing. It just takes too long,” said Wang. “But if you have a computing device that can do the analysis within the body, it could be possible.”
Using real cardiac mapping data from a donor human heart, the team showed the stretchable array could locate wavefront positions with 99.6% accuracy, even while the device was stretched to more than one and a half times its normal length.

In a separate demonstration, a neural network encoded in the array analyzed a combination of vital signs and personal health data—including cholesterol levels, blood sugar, maximum heart rate and ECG readings—to assess a patient’s risk of heart attack, achieving 83.5% accuracy.

Wang sees this computing array as one component of a fully integrated, body-compatible health platform. His lab is now working to pair the computing array with stretchable wireless communication components and improved sensors, moving toward a system that can sense, analyze and respond to health data as a fully integrated whole.

“Instead of sending data away to a remote server, we can begin making sense of it right where life is happening,” said Fangfang Xia, a computer scientist at Argonne National Laboratory and co-senior author of the study.

SHENZHEN, CHINA – JUNE 29th, 2026 – MemoMind, the newly launched AI hardware brand incubated by XGIMI, today announces that its first AI glasses, MemoMind One, are officially available to order. Following their debut at CES 2026 in Las Vegas and showcase at MWC 2026 in Barcelona, MemoMind One marks XGIMI’s expansion beyond projection technology and into AI-powered wearables - bringing more than a decade of optical engineering expertise into a new category.

Designed for everyday use, MemoMind One blends ultralight comfort with adaptive intelligence, delivering AI assistance that works quietly in the background. The glasses combine dual-eye display technology with integrated audio and a multi-LLM hybrid operating system to support real-time translation, intelligent note-taking, contextual assistance, navigation, and more.

MemoMind One is available in three frame styles – Nomad (Square-Round), Archive (Round), and Gotham (Square) – alongside seven customizable color options to better match individual styles and preferences. Each frame is engineered with a focus on long-term comfort, durability, and all-day wear, with prescription lens support available. Under standard usage, MemoMind One delivers up to 16 hours of battery life, ensuring reliable performance throughout an entire day of use.

About XGIMI

Since 2013, the state-of-the-art XGIMI projectors have helped countless people worldwide to create genuinely immersive audio-visual experiences. Working with reputable partners like Google, Harman Kardon, and Texas Instruments, XGIMI builds all-in-one entertainment devices, perfected due to their user-oriented philosophy. Through industry-leading innovation, streamlined setups, and unique designs, XGIMI always strives to develop the best home and portable projectors for everyone to enjoy. Learn more at XGIMI Projector Technology.

‍

About MemoMind

MemoMind is an AI hardware company incubated by XGIMI, the world’s leading smart projector brand. Built on years of optical engineering expertise and a refined design philosophy, MemoMind brings a hardware-first approach to everyday AI. Designed to feel natural rather than intrusive, MemoMind focuses on delivering AI that works

quietly in the background, supporting users with clarity, context, and intention. Every product is crafted to be comfortable, intuitive, and seamlessly integrated into daily life, enabling AI to become more effortless, more personal, and more human. Crafted for the mindful, MemoMind believes the most powerful technology is the kind you barely notice – until you need it.

‍

Pricing and Availability

MemoMind One is now available to order on Kickstarter, with shipping expected later on this summer.

Despite the fact that companies like Whoop have been there for years, the Fitbit Air has taken the wearable market by storm, selling out at many stores and maybe starting a new trend of screenless fitness tracker bands.

The Fitbit Air is a $99 fitness tracker that doesn't have a screen or buttons, is compatible with both iOS and Android smartphones, and doesn't require a membership. It hardly even resembles wearable technology because it is so light and cozy.

Without even considering hiring basketball player Steph Curry as a Performance Advisor, Google has accomplished this in a few crucial ways. First of all, it's reasonable price makes it a far more affordable choice than companies like Whoop, reports Chris Martin in Tech Advisor.

While appearing to be on its way out with years between the Air and the previous generation, the Fitbit brand still has significant influence. Additionally, Google has stated that the Pixel Watch models will essentially replace the Fitbit devices.

The buzz and early success of the Fitbit Air give Google a good opportunity to extend its wearable game. I feel the corporation would be crazy not to follow up the Air with a Fitbit smart ring.

For many, the Fitbit Air's price of less than $100 makes it an obvious choice. In addition to the fact that the Fitbit brand is well-known and trusted, spending many times more on a rival is a considerably bigger purchase choice.

Read more Pebble Bringing Back Its E-Paper Smartwatches

At a comparable price, a Fitbit smart ring would be extremely popular. It would be four times less expensive than the Samsung Galaxy Ring, five times less expensive than the more elegant Oura Ring 5 finishes, and still less expensive than even the "cheap" smart rings that are now on the market.

Not to mention, low-cost gadgets like the Air don't need to generate enormous profits when one of their goals is to encourage consumers to sign up for Google Health.

Google has to seize this market opportunity right away.

One argument against this device could be that the smart ring is unnecessary for someone who recently purchased a Fitbit Air.

It doesn't have to be one or the other, though. For more accurate data and possibly longer battery life (as the Galaxy Ring does when used with a Galaxy Watch), they might operate concurrently (as the Air does with a Pixel Watch).

Alternatively, depending on your preferences and practicality, you might alternate between the two for certain settings and situations.

It makes perfect sense to get a Fitbit Ring. Google might dominate the market if it packs the Air's data-first, screen-free mentality into an inexpensive smart ring.

Samsung announced its next smart ring, presumably named Galaxy Ring 2 just after the new Oura Ring 5 hit the shelves. Compared to its predecessor, the Oura Ring 5 is roughly 40% smaller with an even longer battery life, although does come with a higher price tag. Given how intense the competition has become over the past two years, it's about time Samsung made a comeback to the smart ring market. How will the Galaxy Ring 2 compare to its competitors?

First off, given the sleeker shape of the Oura Ring 5, it wouldn't be shocking if Samsung adopted a similar "smaller but tougher" strategy for its own smart ring in order to increase comfort, reports Tech Radar.

Additionally, Samsung might learn from Oura and eliminate skin contact bumps from the ring's interior while increasing its battery life. We also anticipated that it would use a solid-state battery.

Pak implied that the Galaxy Ring 2 won't be the greatest change, despite the likelihood of design improvements. He said, "It's really about what services you create on the top layer. If you look at the comparison of other rings, regardless of the competitor, the sensors are not that different right now." What you actually notice is the software differentiation.

In light of these comments, the Galaxy Ring 2 will prioritize stronger software integration over hardware reupholstery. Pak added that Samsung intends to expand its networked environment in order to provide consumers with more precise measurements and a deeper understanding of their health-related behaviors.

Related Samsung Launches Galaxy Watch8 Series

Samsung uses the Samsung Health app to combine your data from the smart ring with data from other devices in its network, rather than relying solely on the metrics collected by the Galaxy Ring 2 to provide a comprehensive picture of your well-being. Galaxy Watches, smartphones, and even its line of SmartThings home appliances might be examples of this, providing you with more specific context for your everyday activities and general well-being.

It's a great win for consumers who are already well-versed in Samsung's gadget ecosystem, but the first-generation Galaxy Ring's inability to support iOS is one of its biggest drawbacks. Although Oura supports iOS, which gives consumers greater incentive to use its wearables over Samsung's, Samsung still has the overall advantage. However, this could change with the Galaxy Ring 2.

Pak strongly implied that the Galaxy Ring will eventually have iOS support in addition to software updates, saying, "I'm smiling but I can't say anything." The biggest surprise of all the new features would be iOS support, which would encourage non-Android customers to choose the Galaxy Ring over competing wearables.